Clinical trials
Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 13 |
| Amgen | 2 |
| Bristol-Myers Squibb | 2 |
| AbbVie | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Baxalta now part of Shire | 1 |
| Charite University, Berlin, Germany | 1 |
| Children's Cancer and Leukaemia Group | 1 |
| Martin Schrappe | 1 |
| Medical College of Wisconsin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 29 |
| Leukemia | 8 |
| Burkitt Lymphoma | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Leukemia, Biphenotypic, Acute | 4 |
| Lymphoma | 4 |
| Myelodysplastic Syndromes | 4 |
| Graft vs Host Disease | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.